Sku |
AAP30561 |
Old sku |
AAPP01213 |
Price |
$99.00 |
Name |
BCL2L13 Peptide - middle region (AAP30561) |
Purchase info |
To purchase this peptide:
- Copy peptide sku
- Click on this link
- Paste into field "Peptide Sku"
|
Size |
100 ug |
Gene |
BCL2L13 |
Alias symbols |
BCL-RAMBO, MIL1, Bcl2-L-13 |
Gene id |
23786 |
Description of target |
BCL2L13 May promote the activation of caspase-3 and apoptosis. |
Swissprot id |
Q9BXK5 |
Protein accession num |
NP_056182 |
Nucleotide accession num |
NM_015367 |
Protein size |
485 amino acids |
Molecular weight |
53kDa |
Application |
WB |
Partner proteins |
GABARAPL2,GABARAPL2 |
Quality control |
The peptide is characterized by mass spectroscopy |
Key reference |
Uhl,G.R., (2008) Arch. Gen. Psychiatry 65 (6), 683-693 |
Description |
This is a synthetic peptide designed for use in combination with anti-BCL2L13 antibody (Catalog #: AVARP02032_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details. |
Product format |
Lyophilized powder |
Reconstitution and storage |
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles. |
Lead time |
Domestic: within 24 hours delivery International: 3-5 business days |
Protocol |
|
Tips |
See our General FAQ page. |
Availability |
In Stock |